Skip to main content
. Author manuscript; available in PMC: 2015 Jun 25.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2013 Jan 25;22(4):580–588. doi: 10.1158/1055-9965.EPI-12-1266

Table 3.

Time since most recent Pap test among women ages 18–29 years by demographic characteristics, NHIS, 2010 (n = 1,622)

Time since most recent Pap P2) ≤12 mo
13–24 mo
25–36 moa
n % (95% CI) n % (95% CI) n % (95% CI)
Age, y 0.057
 18–29 1182 73.1 (70.4–75.6) 317 19.3 (17.0–21.9) 123 7.6 (6.3–9.2)
 18–21 270 78.3 (72.5–83.1) 56 15.8 (11.6–21.2) b
 22–25 445 74.7 (70.1–78.8) 110 18.4 (14.6–23.0) 41 6.9 (4.8–9.7)
 26–29 467 68.0 (63.5–72.1) 151 22.6 (19.0–26.5) 57 9.5 (6.9–12.8)
Race/ethnicity 0.052
 Non-Hispanic White 584 72.4 (68.6–75.9) 161 20.2 (17.0–23.8) 59 7.4 (5.7–9.6)
 Non-Hispanic Black 254 78.6 (72.4–83.7) 58 16.2 (11.9–21.7) b
 Asian 54 66.8 (52.2–78.8) b b
 Hispanic or Latino 285 71.7 (66.5–76.5) 75 17.7 (14.0–22.1) 39 10.6 (7.3–15.0)
 Otherc b b b
Education 0.167
 <High school 146 69.5 (61.7–76.3) 51 19.5 (14.3–26.1) b
 High school graduate 273 69.0 (63.0–74.4) 76 22.3 (17.4–28.1) b
 Some college 474 76.9 (72.2–80.6) 105 15.9 (12.7–19.7) 47 7.2 (5.2–9.8)
 College graduate 289 72.4 (65.9–78.1) 84 21.7 (16.6–27.7) b
% Poverty level 0.666
 <200% 735 73.9 (70.3–77.3) 200 19.5 (16.4–23.0) 72 6.6 (5.0–8.6)
 200%–<400% 234 71.9 (64.9–77.9) 62 20.1 (14.8–26.7) b
 ≥400% 213 72.3 (65.4–78.3) 55 18.2 (13.2–24.7) b
Marital status 0.426
 Never married 611 73.5 (69.2–77.3) 162 18.6 (15.4–22.4) 69 7.9 (5.9–10.5)
 Married/living with partner 511 73.0 (68.7–76.8) 139 20.4 (17.0–24.1) 45 6.7 (4.8–9.2)
 Widowed/divorced/separated 59 68.7 (53.8–80.5) b b
Healthcare coverage 0.072
 Private only 361 73.3 (68.1–77.8) 91 18.3 (14.3–23.1) 39 8.4 (5.8–12.2)
 Public onlyd 299 78.5 (72.4–83.6) 56 16.5 (11.8–22.6) b
 Both private and public 291 75.3 (69.9–79.9) 74 18.4 (14.4–23.2) b
 None 228 66.6 (60.8–72.0) 93 22.7 (18.1–27.9) 41 10.7 (7.7–14.7)
Usual source of healthcare <0.001
 Yes 978 75.8 (72.9–78.6) 237 18.0 (15.5–20.9) 75 6.2 (4.8–7.8)
 No 203 61.5 (55.1–67.6) 80 24.8 (19.2–31.3) 48 13.7 (9.9–18.5)
Ever heard of HPV 0.366
 Yes 962 73.9 (70.8–76.7) 243 18.6 (16.0–21.5) 97 7.5 (6.1–9.3)
 No 216 69.0 (62.6–74.8) 74 23.0 (17.8–29.2) b
HPV vaccine status 0.606
 Vaccinated 220 75.6 (68.6–81.5) 52 17.9 (12.6–24.9) b
 Not vaccinated 950 72.5 (69.6–75.2) 260 19.6 (17.2–22.3) 106 7.9 (6.3–9.9)
Ever given birth to a live born infant 0.238
 Yes 565 70.2 (66.0–74.1) 162 21.5 (18.0–25.5) 61 8.2 (6.1–11.0)
 No 616 75.1 (71.3–78.6) 155 17.7 (14.7–21.2) 62 7.2 (5.4–9.4)
Currently taking birth controle <0.001
 Yes 534 82.5 (79.1–85.4) 100 13.4 (10.8–16.5) 32 4.1 (2.7–6.1)
 No 642 65.9 (62.1–69.5) 214 23.7 (20.3–27.4) 91 10.4 (8.5–12.8)
Doctor recommended most recent Pap testf 0.043
 Yes 618 73.2 (69.2–76.9) 168 20.3 (17.0–24.1) 57 6.4 (4.7–8.7)
 No 555 74.0 (70.0–77.6) 142 18.2 (15.2–21.7) 55 7.8 (5.9–10.3)

NOTE: Includes all women who report ever having a Pap test, excludes women reporting hysterectomy, women who report an abnormal Pap in last 3 years, and women who reported their last Pap was not part of a regular screening exam.

a

Does not include responses “more than 3 years but not more than 5 years”; “over 5 years” because this study sample excludes women who reported an abnormal Pap in the last 3 years, thereby excluding women who report most recent Pap > 3 year ago. “Refused” and “don’t know” excluded from analysis.

b

Estimates are considered statistically unreliable and are suppressed if the cell size is based on fewer than 30 sample cases.

c

“Other” = non-Hispanic all other race groups.

d

Medicare, Medicaid (Military defined as private).

e

Pills, implants, shots.

f

“Did not see a doctor on the past 12 months” included in analysis, but suppressed in this table.